TRANSBIOMED
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and intends to use the funding to begin clinical validation of its innovations in different Spanish hospitals. Transbiomed aims to propose the device as an alternative to biopsy to determine the existence of this type of cancer. The target is to start commercializing the device by 2013.
TRANSBIOMED
Social Links:
Industry:
Biotechnology Clinical Trials Health Diagnostics Medical
Founded:
2007-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.transbiomed.net
Total Employee:
1+
Status:
Closed
Total Funding:
1.2 M EUR
Similar Organizations
BioXpedia
BioXpedia is a contract research laboratory focusing on delivering high quality cost effective Targeted Biomarker Screening to pre-clinical.
EntomoPharm
EntomoPharm, a biotechnology company, develops insect based screening models for predicting ADMET properties of chemical agents.
Henogen
Henogen is a biotechnology company addressing biomanufacturing issues under the general umbrella "from gene to the clinical product.
MTM Laboratories
MTM Laboratories manufactures in-vitro diagnostics for the early-detection and diagnosis of cervical and other cancers.
Proteo Biotech
Proteo Biotech expertise in clinical technology with the discovery and development of medical treatment for the prevention of diseases.
Current Employees Featured
Founder
Investors List
Inveready
Inveready investment in Venture Round - Transbiomed
Ministry of Business, Innovation and Employment
Ministry of Business, Innovation and Employment investment in Venture Round - Transbiomed
More informations about "Transbiomed"
Transbiomed 2025 Company Profile: Valuation, Investors
Transbiomed General Information Description. Developer of non-invasive molecular diagnostic therapies. The company is focused on biomarker discovery and development through to …See details»
Transbiomed - Crunchbase Company Profile & Funding
Transbiomed is a Barcelona, Spain-based biotechnolgy company. The company, has developed a urine test that allows early diagnosis of prostate cancer and …See details»
Transbiomed - VentureRadar
" TRANSBIOMED, the first spin-off of the Vall d'Hebron Institute for Research (VHIR) in Barcelona, was founded in December 2007 by Dr. Jaume Reventós, Andreas Doll and Miguel …See details»
Transbiomed - Headquarter Location, Corporate Office Address …
Transbiomed is Biotechnology in Spain that focus on pivotal clinical trials business. Founded in 2007. They cover business area such as developer, non-invasive molecular diagnostic …See details»
Transbiomed - 2025 Company Profile, Funding
Transbiomed - Provider of genomics and proteomics based molecular diagnostics solutions. This company is not active anymore. Raised a total funding of …See details»
Transbiomed - Products, Competitors, Financials, Employees ...
Feb 10, 2013 Transbiomed is a Spanish biotech company aimed at developing new in vitro molecular diagnostics based on genomic and proteomic technologies to target large markets …See details»
Transbiomed - Funding, Financials, Valuation & Investors
Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. Search Crunchbase. ... How much funding has this …See details»
Transbiomed - Raised $1.63M Funding from 2 investors - Tracxn
Feb 27, 2025 Transbiomed has raised a total funding of $1.63M over 1 round from 2 investors. Investor includes Inveready. Their latest funding round was of $1.63M on Feb 19, 2011 .See details»
Transbiomed CEO, Founder, Key Executive Team, Board of …
Explore {Transbiomed's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Amadix acquires Transbiomed - 2013-02-10 - Crunchbase
Feb 10, 2013 Transbiomed Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. Acquiring Organization: …See details»
OOO "TRANSBIOMED": owners, founders, management, details
Full name of the organization: OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "TRANSBIOMED" TIN: 7723343387. KPP: 772301001. PSRN: 1037723034172. Location: …See details»
Transbiomed - Founders and Board of Directors - Tracxn
Mar 21, 2025 Swift Debt Relief-Costa Mesa based, 2021 founded, Unfunded company; Sir Grout Denver-Denver based, 2007 founded, Unfunded company; Sabari Crop-Chennai based, 1987 …See details»
Transbiomed - CB Insights
Transbiomed.net. Overview & Products; Financials; ... Funding, Valuation & Revenue. 1 Fundings. Transbiomed's latest funding round was a Merger for on February 10, 2013. Date. Round. …See details»
Transbiomed - VentureRadar
TRANSBIOMED, the first spin-off of the Vall d'Hebron Institute for Research (VHIR) in Barcelona, was founded in December 2007 by Dr. Jaume Reventós, Andreas Doll and Miguel Abal …See details»
Transbiomed se fusiona con la biotecnológica Amadix
Feb 7, 2013 Transbiomed, la primera spin-off del Vall d’Hebron Institut de Recerca (VHIR), ha vendido el 100 por cien de sus acciones a la empresa biotecnológica Amadix. El Dr. Jaume …See details»
Transbiomed Asset Profile | Preqin
Founded in 2007, Transbiomed is a Barcelona, Spain-based biotechnology company. It developed a urine test that allows early diagnosis of prostate cancer and intends to use the …See details»
Inveready takes a stake in Transbiomed, the first spin-off of VHIR
Inveready Seed Capital, Venture Capital led and participated by Inveready Group, has announced its investment in the company Transbiomed in its first round of funding. Inveready has taken a …See details»
Transbiomed - Contacts, Employees, Board Members, Advisors
Transbiomed is a Spain-based biotechnology company developing a urine test for the early detection and diagnosis of prostate cancer. ... Experience the new Crunchbase, powered by AI …See details»
SFR TransBioMed - Université de Bordeaux - divorce - doczz.net
SFR TransBioMed 2013 Bilan d’activité Foreword The Federative Research Structure TransBioMed was created in January 2011. It gathers about 500 people belonging to 12 …See details»
From morphology to single-cell molecules: high-resolution 3D …
Mar 3, 2025 High-resolution three-dimensional (3D) tissue analysis has emerged as a transformative innovation in the life sciences, providing detailed insights into the spatial …See details»